Mortality and causes of death in patients with Parkinson's disease: a nationwide population-based cohort study

被引:15
作者
Ryu, Dong-Woo [1 ]
Han, Kyungdo [2 ]
Cho, A-Hyun [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Neurol, Seoul, South Korea
[2] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
关键词
Parkinson's disease; mortality; cause of death; population characteristics; epidemiology; RISK; SURVIVAL;
D O I
10.3389/fneur.2023.1236296
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Parkinson's disease (PD) is a neurodegenerative disease involving multiple systems that can a ect mortality. This study aimed to compare all-cause and cause-specific mortality between people with PD and without PD. Methods: This population-based prospective cohort study is based on Korean National Health Insurance Service data. The primary outcome was the hazard ratio (HR) of all-cause and cause-specific mortality for PD from 2010 to 2019. Cox proportional hazards regression was applied to calculate HRs under crude and three adjusted models with epidemiologic variables. Results: A total of 8,220 PD patients and 41,100 age- and sex-matched controls without PD were registered. Ten-year mortality was 47.9% in PD patients and 20.3% in non-PD controls. The mortality rate was higher among older and male participants. The leading cause of death in PD was nervous system diseases (38.73%), and 97.1% of those were extrapyramidal and movement disorders, followed by circulatory diseases (15.33%), respiratory diseases (12.56%), and neoplasms (9.7%). PD contributed to an increased risk of all-cause death with an HR of 2.96 (95% CI = 2.84-3.08). HRs of death for PD were 3.07 (95% CI = 2.74-3.45) from respiratory diseases, 1.93 (95% CI = 1.75-2.13) from circulatory diseases, 2.35 (95% CI = 2.00-2.77) from external causes, and 2.69 (95% CI = 2.10-3.43) from infectious diseases. Conclusion: These results showed that PD was related to a higher risk ofmortality in all ages and sexes. The leading causes of death in PD were nervous, circulatory, respiratory, infectious diseases, and external causes.
引用
收藏
页数:13
相关论文
共 40 条
[1]   The Impact of Type 2 Diabetes in Parkinson's Disease [J].
Athauda, Dilan ;
Evans, James ;
Wernick, Anna ;
Virdi, Gurvir ;
Choi, Minee L. ;
Lawton, Michael ;
Vijiaratnam, Nirosen ;
Girges, Christine ;
Ben-Shlomo, Yoav ;
Ismail, Khalida ;
Morris, Huw ;
Grosset, Donald ;
Foltynie, Thomas ;
Gandhi, Sonia .
MOVEMENT DISORDERS, 2022, 37 (08) :1612-1623
[2]   Diabetes mellitus, prediabetes and the risk of Parkinson's disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases [J].
Aune, Dagfinn ;
Schlesinger, Sabrina ;
Mahamat-Saleh, Yahya ;
Zheng, Bang ;
Udeh-Momoh, Chinedu T. T. ;
Middleton, Lefkos T. T. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2023, 38 (06) :591-604
[3]   Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample [J].
Beydoun, Hind A. ;
Beydoun, May A. ;
Mishra, Nishant K. ;
Rostant, Ola S. ;
Zonderman, Alan B. ;
Eid, Shaker M. .
PARKINSONISM & RELATED DISORDERS, 2017, 35 :30-35
[4]   A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population [J].
Brakedal, Brage ;
Toker, Lilah ;
Haugarvoll, Kristoffer ;
Tzoulis, Charalampos .
NPJ PARKINSONS DISEASE, 2022, 8 (01)
[5]   Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis [J].
Breckenridge, Charles B. ;
Berry, Colin ;
Chang, Ellen T. ;
Sielken, Robert L., Jr. ;
Mandel, Jack S. .
PLOS ONE, 2016, 11 (04)
[6]   Why is there motor deterioration in Parkinson’s disease during systemic infections-a hypothetical view [J].
Florian Brugger ;
Roberto Erro ;
Bettina Balint ;
Georg Kägi ;
Paolo Barone ;
Kailash P Bhatia .
npj Parkinson's Disease, 1 (1)
[7]   DOES LEVODOPA THERAPY DELAY DEATH IN PARKINSONS-DISEASE - A REVIEW OF THE EVIDENCE [J].
CLARKE, CE .
MOVEMENT DISORDERS, 1995, 10 (03) :250-256
[8]   Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence [J].
Cuenca-Bermejo, Lorena ;
Almela, Pilar ;
Navarro-Zaragoza, Javier ;
Fernandez Villalba, Emiliano ;
Gonzalez-Cuello, Ana-Maria ;
Laorden, Maria-Luisa ;
Herrero, Maria-Trinidad .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
[9]   Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts [J].
Cullinane, Patrick W. ;
Fernandez, Eduardo de Pablo ;
Konig, Annekatrin ;
Outeiro, Tiago Fleming ;
Jaunmuktane, Zane ;
Warner, Thomas T. .
MOVEMENT DISORDERS, 2023, 38 (02) :162-177
[10]   Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease [J].
De Pablo-Fernandez, Eduardo ;
Lees, Andrew J. ;
Holton, Janice L. ;
Warner, Thomas T. .
JAMA NEUROLOGY, 2019, 76 (04) :470-479